Drug Industry Seeks Ways to Capitalize on Election Success

[Guest guest]

Drug Industry Seeks Ways to Capitalize on Election Success

By ROBERT PEAR and RICHARD A. OPPEL Jr.

 

ASHINGTON, Nov. 20 - Having spent more than $30 million to help elect

their

allies to Congress, the major drug companies are devising ways to

capitalize

on their electoral success by securing favorable new legislation and

countering the pressure that lawmakers in both parties feel to lower

the

cost of prescription drugs, industry officials say.

 

http://www.nytimes.com/2002/11/21/politics/21DRUG.html